1571 related articles for article (PubMed ID: 30326284)
21. Enhanced Dissolution of a Porous Carrier-Containing Ternary Amorphous Solid Dispersion System Prepared by a Hot Melt Method.
Hanada M; Jermain SV; Williams RO
J Pharm Sci; 2018 Jan; 107(1):362-371. PubMed ID: 28989021
[TBL] [Abstract][Full Text] [Related]
22. Novel Hot Melt Extruded Matrices of Hydroxypropyl Cellulose and Amorphous Felodipine-Plasticized Hydroxypropyl Methylcellulose as Controlled Release Systems.
Yi S; Wang J; Lu Y; Ma R; Gao Q; Liu S; Xiong S
AAPS PharmSciTech; 2019 Jun; 20(6):219. PubMed ID: 31201583
[TBL] [Abstract][Full Text] [Related]
23. In Vivo Performance of Innovative Polyelectrolyte Matrices for Hot Melt Extrusion of Amorphous Drug Systems.
Ditzinger F; Wieland R; Statelova M; Vertzoni M; Holm R; Kuentz M
Mol Pharm; 2020 Aug; 17(8):3053-3061. PubMed ID: 32589437
[TBL] [Abstract][Full Text] [Related]
24. Mid-infrared spectroscopy as a polymer selection tool for formulating amorphous solid dispersions.
Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
J Pharm Pharmacol; 2014 Feb; 66(2):244-55. PubMed ID: 24433425
[TBL] [Abstract][Full Text] [Related]
25. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.
Ghebremeskel AN; Vemavarapu C; Lodaya M
Int J Pharm; 2007 Jan; 328(2):119-29. PubMed ID: 16968659
[TBL] [Abstract][Full Text] [Related]
26. Chrono modulated multiple unit particulate systems (MUPS) via a continuous hot melt double extrusion technique: Investigation of the formulation and process suitability.
Kallakunta VR; Sarabu S; Dudhipala N; Janga KY; Bandari S; Zhang F; Repka MA
Eur J Pharm Biopharm; 2021 Nov; 168():184-194. PubMed ID: 34464695
[TBL] [Abstract][Full Text] [Related]
27. Part II: bioavailability in beagle dogs of nimodipine solid dispersions prepared by hot-melt extrusion.
Zheng X; Yang R; Zhang Y; Wang Z; Tang X; Zheng L
Drug Dev Ind Pharm; 2007 Jul; 33(7):783-9. PubMed ID: 17654027
[TBL] [Abstract][Full Text] [Related]
28. Impact of polymer type on bioperformance and physical stability of hot melt extruded formulations of a poorly water soluble drug.
Mitra A; Li L; Marsac P; Marks B; Liu Z; Brown C
Int J Pharm; 2016 May; 505(1-2):107-14. PubMed ID: 27012984
[TBL] [Abstract][Full Text] [Related]
29. The utilization of drug-polymer interactions for improving the chemical stability of hot-melt extruded solid dispersions.
Guo Z; Lu M; Li Y; Pang H; Lin L; Liu X; Wu C
J Pharm Pharmacol; 2014 Feb; 66(2):285-96. PubMed ID: 24433427
[TBL] [Abstract][Full Text] [Related]
30. Effects of Surfactants on Itraconazole-HPMCAS Solid Dispersion Prepared by Hot-Melt Extrusion I: Miscibility and Drug Release.
Solanki NG; Lam K; Tahsin M; Gumaste SG; Shah AV; Serajuddin ATM
J Pharm Sci; 2019 Apr; 108(4):1453-1465. PubMed ID: 30395834
[TBL] [Abstract][Full Text] [Related]
31. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
Ghebremeskel AN; Vemavarapu C; Lodaya M
Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443
[TBL] [Abstract][Full Text] [Related]
32. Selection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersions.
Djuris J; Milovanovic S; Medarevic D; Dobricic V; Dapčević A; Ibric S
Int J Pharm; 2019 Jan; 554():190-200. PubMed ID: 30414899
[TBL] [Abstract][Full Text] [Related]
33. Probing the Molecular-Level Interactions in an Active Pharmaceutical Ingredient (API) - Polymer Dispersion and the Resulting Impact on Drug Product Formulation.
Yang F; Su Y; Small J; Huang C; Martin GE; Farrington AM; DiNunzio J; Brown CD
Pharm Res; 2020 May; 37(6):94. PubMed ID: 32405662
[TBL] [Abstract][Full Text] [Related]
34. How changes in molecular weight and PDI of a polymer in amorphous solid dispersions impact dissolution performance.
Auch C; Harms M; Mäder K
Int J Pharm; 2019 Feb; 556():372-382. PubMed ID: 30553957
[TBL] [Abstract][Full Text] [Related]
35. Continuous production of itraconazole-based solid dispersions by hot melt extrusion: Preformulation, optimization and design space determination.
Thiry J; Lebrun P; Vinassa C; Adam M; Netchacovitch L; Ziemons E; Hubert P; Krier F; Evrard B
Int J Pharm; 2016 Dec; 515(1-2):114-124. PubMed ID: 27720874
[TBL] [Abstract][Full Text] [Related]
36. Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug.
Lakshman JP; Cao Y; Kowalski J; Serajuddin AT
Mol Pharm; 2008; 5(6):994-1002. PubMed ID: 19434852
[TBL] [Abstract][Full Text] [Related]
37. An investigation into the influence of drug-polymer interactions on the miscibility, processability and structure of polyvinylpyrrolidone-based hot melt extrusion formulations.
Chan SY; Qi S; Craig DQ
Int J Pharm; 2015 Dec; 496(1):95-106. PubMed ID: 26428633
[TBL] [Abstract][Full Text] [Related]
38. Application and functional characterization of POVACOAT, a hydrophilic co-polymer poly(vinyl alcohol/acrylic acid/methyl methacrylate) as a hot-melt extrusion carrier.
Xu M; Zhang C; Luo Y; Xu L; Tao X; Wang Y; He H; Tang X
Drug Dev Ind Pharm; 2014 Jan; 40(1):126-35. PubMed ID: 23336809
[TBL] [Abstract][Full Text] [Related]
39. Formulating Amorphous Solid Dispersions: Impact of Inorganic Salts on Drug Release from Tablets Containing Itraconazole-HPMC Extrudate.
Takano R; Maurer R; Jacob L; Stowasser F; Stillhart C; Page S
Mol Pharm; 2020 Aug; 17(8):2768-2778. PubMed ID: 31794228
[TBL] [Abstract][Full Text] [Related]
40. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing.
Alhijjaj M; Belton P; Qi S
Eur J Pharm Biopharm; 2016 Nov; 108():111-125. PubMed ID: 27594210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
